NxStage Medical, Inc.
DelistedCIK 1333170fmd_1WJ93VJ4P5DKY3VYRNX8S0D6T3Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Sep 30, 2018, 36 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 242 | 263 | 302 | – | – | – |
| Cost of revenue | 112 | 121 | 140 | 149 | 161 | 186 | 205 | 214 | 226 |
| Gross profit | 37 | 58 | 78 | 93 | 103 | 116 | 131 | 152 | 168 |
| Research and development | 10 | 13 | 14 | 17 | 19 | 23 | 26 | 31 | 40 |
| Selling, general and administrative | 50 | 57 | 61 | 68 | 80 | 89 | 94 | 97 | 110 |
| Total operating expenses | 73 | 85 | 93 | 104 | 120 | 138 | 146 | 156 | 182 |
| Operating income | (36) | (26) | (16) | (11) | (18) | (22) | (15) | (4) | (14) |
| Interest expense | 7 | 5 | 5 | 3 | 1 | – | – | – | – |
| Interest and investment income | 0 | 0 | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | (7) | (4) | (5) | (3) | (1) | (1) | (1) | (2) | (2) |
| Income before taxes | (43) | (31) | (21) | (14) | (19) | (23) | (15) | (6) | (15) |
| Income tax expense | 0 | 1 | 1 | 1 | (0) | 1 | 1 | 1 | (0) |
| Net income from continuing operations | (43) | (32) | (21) | (15) | (19) | (24) | (16) | (7) | (15) |
| Net income | (43) | (32) | (21) | (15) | (19) | (24) | (15) | (5) | (14) |
| Net income to common shareholders | – | – | – | – | – | – | (15) | (5) | (14) |